FDA Approved: RIZATRIPTAN BENZOATE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approves the original application for Rizatriptan benzoate (Rizatriptan benzoate) by Rising Pharma Holdings, Inc. (ANDA 202490).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Rizatriptan Benzoate (rizatriptan benzoate)

Snippet

ORIG AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)